medroxyprogesterone acetate
- RxCUI
- 1000112
- RxNorm name
- medroxyprogesterone acetate
- Term type
- PIN
- Status
- Active
- Updated
- 2026-10-21 00:27:13
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- NO
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| medroxyprogesterone | 6691 |
Source Vocabulary Codes#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | REMEDYREPACK INC. | a0a92717-c1cb-40eb-a95a-1c5dfd32cfc0 | 2026-09-04 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | REMEDYREPACK INC. | 1020bb60-4f13-4cd7-aaa1-c556752c84b7 | 2026-08-31 | Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | Prasco Laboratories | 987496bf-b4b0-409b-b745-f52ed0871f4e | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Depo-Provera | MEDROXYPROGESTERONE ACETATE | Pharmacia & Upjohn Company LLC | 199cf13e-0859-4a73-9b45-e700d0cd1049 | 2026-08-25 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | REMEDYREPACK INC. | e3dfd683-d44e-427b-af06-70b9b698e016 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Provera | MEDROXYPROGESTERONE ACETATE | Pharmacia & Upjohn Company LLC | a586be28-96af-4fed-a13f-9b94fd4c7405 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Preferred Pharmaceuticals, Inc. | 37275fd0-eb24-40a4-a93f-b818bb98414e | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | Mylan Pharmaceuticals Inc. | 2627eb11-06bf-4a45-9172-094468e3ca07 | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | A-S Medication Solutions | 5e817926-ba15-4d16-9463-88f6ff3bd3ac | 2026-02-23 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Xiromed LLC | 24544a5d-0cf5-a099-b57c-6e0843a40532 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| medroxyprogesterone acetate | MEDROXYPROGESTERONE ACETATE | Amneal Pharmaceuticals LLC | 6457d70a-2f25-4935-8511-726d988f7a03 | 2026-01-19 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| MEDROXYPROGESTERONE ACETATE | MEDROXYPROGESTERONE ACETATE | Eugia US LLC | 0655670a-d127-4e08-8a23-ace64b2503b2 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | A-S Medication Solutions | 816b9fd2-bc55-496b-846a-cabe7bbdecd6 | 2026-01-06 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Northwind Health Company, LLC | 0de6142f-a78e-ae58-e063-6394a90adff0 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Amphastar Pharmaceuticals, Inc. | fda1aa8a-5739-482a-b4f6-9741ef4d9977 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Depo-SubQ Provera | MEDROXYPROGESTERONE ACETATE | Pharmacia & Upjohn Company LLC | 390087a6-f3c3-4f0b-a930-79acf412f153 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | PD-Rx Pharmaceuticals, Inc. | 6a541749-5d14-44aa-a409-5e51f5bbf929 | 2025-10-02 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | A-S Medication Solutions | bfdf335d-1cbb-4533-9fde-99a9c71f7504 | 2025-06-12 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | A-S Medication Solutions | 788df737-e990-4b5e-accd-af13c3b2bf8b | 2025-06-12 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
| Medroxyprogesterone Acetate | MEDROXYPROGESTERONE ACETATE | Amneal Pharmaceuticals NY LLC | a80560e1-96dd-4380-b3e1-d52719ccdd4b | 2025-02-07 | Boxed warning, Warnings, Adverse reactions | MEDROXYPROGESTERONE ACETATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | G03DA | Pregnen (4) derivatives | ATC1-4 | medroxyprogesterone | |
| ATC | L02AB | Progestogens | ATC1-4 | medroxyprogesterone | |
| ATC | G03AC | Progestogens | ATC1-4 | medroxyprogesterone | |
| ATC | G03AA | Progestogens and estrogens, fixed combinations | ATC1-4 | estradiol / medroxyprogesterone | |
| FDASPL | D045167 | Progesterone Congeners | CHEM | has_chemical_structure | medroxyprogesterone |
| FDASPL | N0000175602 | Progestin | EPC | has_epc | medroxyprogesterone |
| MEDRT | D008525 | Medroxyprogesterone | CHEM | has_ingredient | medroxyprogesterone |
| MEDRT | D017258 | Medroxyprogesterone Acetate | CHEM | has_ingredient | medroxyprogesterone acetate |
| MEDRT | D000568 | Amenorrhea | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D000568 | Amenorrhea | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D002292 | Carcinoma, Renal Cell | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D002292 | Carcinoma, Renal Cell | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D002543 | Cerebral Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D002543 | Cerebral Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D004714 | Endometrial Hyperplasia | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D004714 | Endometrial Hyperplasia | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D016889 | Endometrial Neoplasms | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D007040 | Hypoventilation | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D007040 | Hypoventilation | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | medroxyprogesterone |
| MEDRT | D011247 | Pregnancy | DISEASE | may_prevent | medroxyprogesterone acetate |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D011655 | Pulmonary Embolism | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D011655 | Pulmonary Embolism | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | may_treat | medroxyprogesterone acetate |
| MEDRT | D014592 | Uterine Hemorrhage | DISEASE | may_treat | medroxyprogesterone |
| MEDRT | D014623 | Vaginal Diseases | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D014623 | Vaginal Diseases | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | D020246 | Venous Thrombosis | DISEASE | ci_with | medroxyprogesterone acetate |
| MEDRT | D020246 | Venous Thrombosis | DISEASE | ci_with | medroxyprogesterone |
| MEDRT | N0000000185 | Progestational Hormone Receptor Agonists | MOA | has_moa | medroxyprogesterone |
| MEDRT | N0000000185 | Progestational Hormone Receptor Agonists | MOA | has_moa | medroxyprogesterone acetate |
| MEDRT | N0000008630 | Decreased Follicle Stimulating Hormone Secretion | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000008630 | Decreased Follicle Stimulating Hormone Secretion | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000008632 | Decreased Growth Hormone Secretion | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000008632 | Decreased Growth Hormone Secretion | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009051 | Gonadotropin Releasing Hormone Alteration | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009051 | Gonadotropin Releasing Hormone Alteration | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009715 | Inhibit Ovarian Follicular Phase | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009715 | Inhibit Ovarian Follicular Phase | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009717 | Inhibit Ovulation | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000009857 | Stimulate Breast Glandular Development | PE | has_pe | medroxyprogesterone |
| MEDRT | N0000009857 | Stimulate Breast Glandular Development | PE | has_pe | medroxyprogesterone acetate |
| MEDRT | N0000000043 | Hepatic Excretion | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000043 | Hepatic Excretion | PK | has_pk | medroxyprogesterone acetate |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | medroxyprogesterone acetate |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | medroxyprogesterone |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | medroxyprogesterone acetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| CODES | DRUGBANK | DB00603 |
| CODES | SNOMEDCT | 126112002 |
| CODES | USP | m47910 |
| CODES | VUID | 4017828 |
| NAMES | Tallman Synonym | medroxyPROGESTERone acetate |
| SOURCES | Source | Drug Bank |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | United States Pharmacopeia |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |